The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | Kazden Alan | Director | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Hu Ben | Director | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 1.0M | — | $0 |
| Dec 19, 2025 | Van Fleet Justin | CFO | Grant(A) | 100K | — | $0 |
| Dec 19, 2025 | White Mark | CEO, Director | Grant(A) | 1.0M | — | $0 |
| Sep 29, 2025 | Kazden Alan | Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Hu Ben | Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 36K | — | $0 |
| Sep 29, 2025 | Osser Leonard | 10% Owner | Grant(A) | 83K | — | $0 |
| Sep 12, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 100K | — | $0 |
| Sep 12, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 203K | — | $0 |
| Sep 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality - Regulatory | Grant(A) | 20K | — | $0 |
| Sep 10, 2025 | Osser Leonard | 10% Owner | Sell(S) | 23K | $0.02 | $463 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 150K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Jul 17, 2025 | Elson Marilyn | 10% Owner | Grant(A) | 30K | — | $0 |
| Mar 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy(P) | 6K | $2.20 | $13K |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 140K | — | $0 |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 125K | — | $0 |
| Feb 26, 2025 | Owens David | Chief Medical Officer, Director | Grant(A) | 654K | — | $0 |
| Feb 26, 2025 | White Mark | President and CEO, Director | Grant(A) | 940K | — | $0 |
| Feb 26, 2025 | White Mark | President and CEO, Director | Grant(A) | 447K | — | $0 |
| Feb 4, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $2.98 | $3K |
| Feb 4, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $3.10 | $3K |
| Jan 28, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $2.70 | $4K |
| Jan 23, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $2.70 | $3K |
| Jan 13, 2025 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $2.50 | $5K |
| Oct 28, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 500 | $2.19 | $1K |
| Sep 30, 2024 | Hu Ben | Director | Grant(A) | 175K | — | $0 |
| Sep 30, 2024 | Bernhard Leslie | Director | Grant(A) | 50K | — | $0 |
| Sep 30, 2024 | Elson Marilyn | 10% Owner | Grant(A) | 700K | — | $0 |
| Sep 23, 2024 | Osser Leonard | Insider | Grant(A) | 700K | — | $0 |
| Aug 13, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $0.95 | $950 |
| Jun 28, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $1.75 | $2K |
| Jun 18, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $0.71 | $1K |
| Jun 10, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 2K | $0.65 | $1K |
| Jun 10, 2024 | Owens David | Chief Medical Officer, Director | Buy(P) | 1K | $0.62 | $620 |
| Sep 28, 2022 | Osser Leonard | Insider | Buy(P) | 10K | $0.40 | $4K |
| Sep 16, 2022 | White Mark | President/CEO, Director | Buy(P) | 25K | $0.40 | $10K |
| Sep 16, 2022 | Owens David | Chief Medical Officer, Director | Buy(P) | 3K | $0.40 | $1K |
| Sep 16, 2022 | Kazden Alan | Director | Buy(P) | 3K | $0.40 | $1K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).